Glycopyrronium Bromide Inhalation Spray(Anovent Pharma)

格隆溴铵吸入喷雾剂（上海谷森医药）

Report date: 2025/08/08 14:27:18

Base Information

Drug NameGlycopyrronium Bromide Inhalation Spray(Anovent Pharma)
Drug Alias NameGlycopyrrolate甘罗溴铵Glycopyrrolate bromide溴环扁比酯Bromure de glycopyrronium +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAnovent Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnovent Pharmaceuticals Co LtdNanchang Gusen biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG